{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:02:30Z","timestamp":1784289750228,"version":"3.55.0"},"reference-count":98,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:00:00Z","timestamp":1645228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"LOEWE DRUID","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Schistosomiasis is a neglected tropical disease affecting more than 200 million people worldwide. Chemotherapy relies on one single drug, praziquantel, which is safe but ineffective at killing larval stages of this parasite. Furthermore, concerns have been expressed about the rise in resistance against this drug. In the absence of an antischistosomal vaccine, it is, therefore, necessary to develop new drugs against the different species of schistosomes. Protein kinases are important molecules involved in key cellular processes such as signaling, growth, and differentiation. The kinome of schistosomes has been studied and the suitability of schistosomal protein kinases as targets demonstrated by RNA interference studies. Although protein kinase inhibitors are mostly used in cancer therapy, e.g., for the treatment of chronic myeloid leukemia or melanoma, they are now being increasingly explored for the treatment of non-oncological conditions, including schistosomiasis. Here, we discuss the various approaches including screening of natural and synthetic compounds, de novo drug development, and drug repurposing in the context of the search for protein kinase inhibitors against schistosomiasis. We discuss the status quo of the development of kinase inhibitors against schistosomal serine\/threonine kinases such as polo-like kinases (PLKs) and mitogen-activated protein kinases (MAP kinases), as well as protein tyrosine kinases (PTKs).<\/jats:p>","DOI":"10.3390\/molecules27041414","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T08:22:19Z","timestamp":1645431739000},"page":"1414","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-5336","authenticated-orcid":false,"given":"Bernardo","family":"Pereira Moreira","sequence":"first","affiliation":[{"name":"Biomedical Research Center Seltersberg  (BFS), Institute of Parasitology, Justus Liebig University Giessen, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H. W.","family":"Weber","sequence":"additional","affiliation":[{"name":"Biomedical Research Center Seltersberg  (BFS), Institute of Parasitology, Justus Liebig University Giessen, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Haeberlein","sequence":"additional","affiliation":[{"name":"Biomedical Research Center Seltersberg  (BFS), Institute of Parasitology, Justus Liebig University Giessen, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika S.","family":"Mokosch","sequence":"additional","affiliation":[{"name":"Institute of Inorganic and Analytical Chemistry, Justus Liebig University Giessen, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0179-5653","authenticated-orcid":false,"given":"Bernhard","family":"Spengler","sequence":"additional","affiliation":[{"name":"Institute of Inorganic and Analytical Chemistry, Justus Liebig University Giessen, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3144-2026","authenticated-orcid":false,"given":"Christoph G.","family":"Grevelding","sequence":"additional","affiliation":[{"name":"Biomedical Research Center Seltersberg  (BFS), Institute of Parasitology, Justus Liebig University Giessen, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1732-9932","authenticated-orcid":false,"given":"Franco H.","family":"Falcone","sequence":"additional","affiliation":[{"name":"Biomedical Research Center Seltersberg  (BFS), Institute of Parasitology, Justus Liebig University Giessen, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,19]]},"reference":[{"key":"ref_1","unstructured":"(2021, December 20). World Health Organization Schistosomiasis. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/schistosomiasis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","article-title":"Schistosomiasis","volume":"4","author":"McManus","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e02582-16","DOI":"10.1128\/AAC.02582-16","article-title":"Praziquantel for schistosomiasis: Single-drug metabolism revisited, mode of action, and resistance","volume":"61","author":"Vale","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijpara.2003.12.003","article-title":"Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment","volume":"34","author":"Cioli","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0014-4894(86)90184-0","article-title":"Schistosoma mansoni: Chemotherapy of infections of different ages","volume":"61","author":"Sabah","year":"1986","journal-title":"Exp. Parasitol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40249-017-0286-2","article-title":"Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?","volume":"6","author":"Bergquist","year":"2017","journal-title":"Infect. Dis. Poverty"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-020-0621-y","article-title":"Schistosomiasis vaccine development: Update on human clinical trials","volume":"27","author":"Molehin","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling","volume":"411","author":"Hunter","year":"2001","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104609","DOI":"10.1016\/j.phrs.2019.104609","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update","volume":"152","author":"Roskoski","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bournez, C., Carles, F., Peyrat, G., Aci-S\u00e8che, S., Bourg, S., Meyer, C., and Bonnet, P. (2020). Comparative assessment of protein kinase inhibitors in public databases and in PKIDB. Molecules, 25.","DOI":"10.3390\/molecules25143226"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Carles, F., Bourg, S., Meyer, C., and Bonnet, P. (2018). PKIDB: A curated, annotated and updated database of protein kinase inhibitors in clinical trials. Molecules, 23.","DOI":"10.3390\/molecules23040908"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Edwards, L.D., Fox, A.W., and Stonier, P.D. (2010). Principles and Practice of Pharmaceutical Medicine, Academic Press. [3rd ed.].","DOI":"10.1002\/9781444325263"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"Drug development for neglected diseases: A deficient market and a public-health policy failure","volume":"359","author":"Trouiller","year":"2002","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: Identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1645\/14-703.1","article-title":"Anthelmintic drug discovery: Into the future","volume":"101","author":"Geary","year":"2015","journal-title":"J. Parasitol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1168243","article-title":"Drug discovery and natural products: End of an era or an endless frontier?","volume":"325","author":"Li","year":"2009","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/molecules20021872","article-title":"Natural products as leads in schistosome drug discovery","volume":"20","author":"Neves","year":"2015","journal-title":"Molecules"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.3390\/ijms14023395","article-title":"Natural products as a source for treating neglected parasitic diseases","volume":"14","author":"Ndjonka","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exppara.2019.02.010","article-title":"In vitro effect of curcumin on Schistosoma species viability, tegument ultrastructure and egg hatchability","volume":"199","author":"Shahat","year":"2019","journal-title":"Exp. Parasitol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00436-008-1311-y","article-title":"In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms","volume":"104","author":"Machado","year":"2009","journal-title":"Parasitol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"111512","DOI":"10.1016\/j.ejmech.2019.07.015","article-title":"Curcumin as tyrosine kinase inhibitor in cancer treatment","volume":"181","author":"Golonko","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.1806797115","article-title":"Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2","volume":"115","author":"Banerjee","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/173614","article-title":"In vitro schistosomicidal activity of some brazilian cerrado species and their isolated compounds","volume":"2012","author":"Cunha","year":"2012","journal-title":"Evid. -Based Complement. Altern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Baier, A., and Szyszka, R. (2020). Compounds from natural sources as protein kinase inhibitors. Biomolecules, 10.","DOI":"10.3390\/biom10111546"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1016\/S0021-9258(18)45614-1","article-title":"Genistein, a specific inhibitor of tyrosine-specific protein kinases","volume":"262","author":"Akiyama","year":"1987","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12639-018-0984-0","article-title":"Genistein: Is the multifarious botanical a natural anthelmintic too?","volume":"42","author":"Tandon","year":"2018","journal-title":"J. Parasit. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s004360050104","article-title":"Effect of root-tuber extract of Flemingia vestita, a leguminous plant, on Artyfechinostomum sufrartyfex and Fasciolopsis buski: A scanning electron microscopy study","volume":"82","author":"Roy","year":"1996","journal-title":"Parasitol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.3389\/fimmu.2018.02781","article-title":"Host regulators of liver fibrosis during human schistosomiasis","volume":"9","author":"Kamdem","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.exppara.2018.01.013","article-title":"Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection","volume":"185","author":"Sobhy","year":"2018","journal-title":"Exp. Parasitol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Chae, H.S., Xu, R., Won, J.Y., Chin, Y.W., and Yim, H. (2019). Molecular targets of genistein and its related flavonoids to exert anticancer effects. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102420"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Li, T., Wang, N., Zhang, T., Zhang, B., Sajeevan, T.P., Joseph, V., Armstrong, L., He, S., Yan, X., and Benjamin Naman, C. (2019). A systematic review of recently reported marine derived natural product kinase inhibitors. Mar. Drugs, 17.","DOI":"10.3390\/md17090493"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nature14412","article-title":"A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria","volume":"520","author":"Mbengue","year":"2015","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1271\/bbb.56.845","article-title":"Antischistosomal Activities of Sesquiterpene Lactones and Steroid Glucosides from Vernonia amygdalina, Possibly Used by Wild Chimpanzees against Parasite-related Diseases","volume":"56","author":"Jisaka","year":"1992","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Mohebali, N., Pandurangan, A.K., Mustafa, M.R., Anandasadagopan, S.K., and Alagumuthu, T. (2020). Vernodalin induces apoptosis through the activation of ROS\/JNK pathway in human colon cancer cells. J. Biochem. Mol. Toxicol., 34.","DOI":"10.1002\/jbt.22587"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"105350","DOI":"10.1016\/j.actatropica.2020.105350","article-title":"Antiparasitic activity of piplartine (piperlongumine) in a mouse model of schistosomiasis","volume":"205","author":"Mengarda","year":"2020","journal-title":"Acta Trop."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.exppara.2010.08.021","article-title":"Schistosoma mansoni: In vitro schistosomicidal activity of piplartine","volume":"127","author":"Nascimento","year":"2011","journal-title":"Exp. Parasitol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.exppara.2012.07.004","article-title":"Schistosoma mansoni: In vitro schistosomicidal activity and tegumental alterations induced by piplartine on schistosomula","volume":"132","author":"Nascimento","year":"2012","journal-title":"Exp. Parasitol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejps.2012.12.003","article-title":"Overview of the therapeutic potential of piplartine (piperlongumine)","volume":"48","author":"Bezerra","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1021\/jm300344v","article-title":"Lessons from natural products chemistry can offer novel approaches for synthetic chemistry in drug discovery miniperspective","volume":"55","author":"Vasilevich","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Thomford, N.E., Senthebane, D.A., Rowe, A., Munro, D., Seele, P., Maroyi, A., and Dzobo, K. (2018). Natural products for drug discovery in the 21st century: Innovations for novel drug discovery. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061578"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/cmdc.201900423","article-title":"Development of Biarylalkyl Carboxylic Acid Amides with Improved Anti-schistosomal Activity","volume":"14","author":"Haeberlein","year":"2019","journal-title":"ChemMedChem"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e2100259","DOI":"10.1002\/ardp.202100259","article-title":"Synthesis and antischistosomal activity of linker- and thiophene-modified biaryl alkyl carboxylic acid derivatives","volume":"354","author":"Haeberlein","year":"2021","journal-title":"Arch. Pharm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1128\/AAC.01537-06","article-title":"In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species","volume":"51","author":"Xiao","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1016\/j.bmc.2015.02.010","article-title":"Elucidation of the in vitro and in vivo activities of bridged 1,2,4-trioxolanes, bridged 1,2,4,5-tetraoxanes, tricyclic monoperoxides, silyl peroxides, and hydroxylamine derivatives against Schistosoma mansoni","volume":"23","author":"Cowan","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.actatropica.2014.12.005","article-title":"Efficacy of SynriamTM, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni","volume":"143","author":"Mossallam","year":"2015","journal-title":"Acta Trop."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1128\/AAC.05371-11","article-title":"In vivo activity of aryl ozonides against Schistosoma species","volume":"56","author":"Keiser","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1128\/AAC.00778-16","article-title":"Discovery of antischistosomal drug leads based on tetraazamacrocyclic derivatives and their metal complexes","volume":"60","author":"Khan","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"105248","DOI":"10.1016\/j.actatropica.2019.105248","article-title":"(\u00b1)-Licarin A and its semi-synthetic derivatives: In vitro and in silico evaluation of trypanocidal and schistosomicidal activities","volume":"202","author":"Meleti","year":"2020","journal-title":"Acta Trop."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"14478","DOI":"10.1038\/ncomms14478","article-title":"Arylmethylamino steroids as antiparasitic agents","volume":"8","author":"Krieg","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"113823","DOI":"10.1016\/j.ejmech.2021.113823","article-title":"Anti-schistosomal activities of quinoxaline-containing compounds: From hit identification to lead optimisation","volume":"226","author":"Padalino","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.bmcl.2016.01.075","article-title":"Antischistosomal activity of N,N\u2032-arylurea analogs against Schistosoma japonicum","volume":"26","author":"Yao","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/acsinfecdis.0c00508","article-title":"Congeners Derived from Microtubule-Active Phenylpyrimidines Produce a Potent and Long-Lasting Paralysis of Schistosoma mansoni in vitro","volume":"7","author":"Monti","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_54","first-page":"1","article-title":"Anthelmintic effects of alkylated diamines and amino alcohols against Schistosoma mansoni","volume":"2013","author":"Fernandes","year":"2013","journal-title":"Biomed Res. Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e2100439","DOI":"10.1002\/cbdv.202100439","article-title":"Synthetic Aurones: New Features for Schistosoma mansoni Therapy","volume":"18","author":"Moraes","year":"2021","journal-title":"Chem. Biodivers."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.parint.2016.10.013","article-title":"Novel synthetic compounds with endoperoxide structure damage juvenile stage of Schistosoma mansoni by targeting lysosome-like organelles","volume":"66","author":"Yamabe","year":"2017","journal-title":"Parasitol. Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"106189","DOI":"10.1016\/j.dib.2020.106189","article-title":"Kinase inhibitor data set for systematic analysis of representative kinases across the human kinome","volume":"32","author":"Laufer","year":"2020","journal-title":"Data Brief"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cmdc.201800755","article-title":"Unpacking the Pathogen Box\u2014An Open Source Tool for Fighting Neglected Tropical Disease","volume":"14","author":"Veale","year":"2019","journal-title":"ChemMedChem"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-019-3747-6","article-title":"Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery","volume":"12","author":"Maccesi","year":"2019","journal-title":"Parasites Vectors"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: New data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-015-1023-y","article-title":"Repurposing of anticancer drugs: In vitro and in vivo activities against Schistosoma mansoni","volume":"8","author":"Cowan","year":"2015","journal-title":"Parasites Vectors"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Gouveia, M.J., Brindley, P.J., G\u00e4rtner, F., Correia Da Costa, J.M., and Vale, N. (2018). Drug repurposing for schistosomiasis: Combinations of drugs or biomolecules. Pharmaceuticals, 11.","DOI":"10.3390\/ph11010015"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.actatropica.2017.08.002","article-title":"Schistosomiasis: Drugs used and treatment strategies","volume":"176","author":"Siqueira","year":"2017","journal-title":"Acta Trop."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","article-title":"Schistosomiasis control: Praziquantel forever?","volume":"195","author":"Cioli","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1002\/cmdc.201800572","article-title":"Chemotherapy for Fighting Schistosomiasis: Past, Present and Future","volume":"13","author":"Rennar","year":"2018","journal-title":"ChemMedChem"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"You, H., McManus, D.P., Hu, W., Smout, M.J., Brindley, P.J., and Gobert, G.N. (2013). Transcriptional Responses of In vivo Praziquantel Exposure in Schistosomes Identifies a Functional Role for Calcium Signalling Pathway Member CamKII. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003254"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1017\/S0031182020001250","article-title":"Use of kinase inhibitors against schistosomes to improve and broaden praziquantel efficacy","volume":"147","author":"Nawaratna","year":"2020","journal-title":"Parasitology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1432-1033.1995.317_c.x","article-title":"Different Susceptibility of Protein Kinases to Staurosporine Inhibition: Kinetic Studies and Molecular Bases for the Resistance of Protein Kinase CK2","volume":"234","author":"Meggio","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0006-291X(86)90008-2","article-title":"Staurosporine, a potent inhibitor of phospholipid Ca++dependent protein kinase","volume":"135","author":"Tamaoki","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ijpara.2010.03.002","article-title":"Schistosoma mansoni Polo-like kinase 1: A mitotic kinase with key functions in parasite reproduction","volume":"40","author":"Long","year":"2010","journal-title":"Int. J. Parasitol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Long, T., Neitz, R.J., Beasley, R., Kalyanaraman, C., Suzuki, B.M., Jacobson, M.P., Dissous, C., McKerrow, J.H., Drewry, D.H., and Zuercher, W.J. (2016). Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004356"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Andrade, L.F., Nahum, L.A., Avelar, L.G.A., Silva, L.L., Zerlotini, A., Ruiz, J.C., and Oliveira, G. (2011). Eukaryotic Protein Kinases (ePKs) of the Helminth Parasite Schistosoma mansoni. BMC Genom., 12.","DOI":"10.1186\/1471-2164-12-215"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"17759","DOI":"10.1038\/srep17759","article-title":"Defining the Schistosoma haematobium kinome enables the prediction of essential kinases as anti-schistosome drug targets","volume":"5","author":"Stroehlein","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Giuliani, S., Silva, A.C., Borba, J.V.V.B., Ramos, P.I.P., Paveley, R.A., Muratov, E.N., Andrade, C.H., and Furnham, N. (2018). Computationally-guided drug repurposing enables the discovery of kinase targets and inhibitors as new schistosomicidal agents. PLOS Comput. Biol., 14.","DOI":"10.1371\/journal.pcbi.1006515"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pt.2017.12.001","article-title":"Kinases: Molecular Stage Directors for Schistosome Development and Differentiation","volume":"34","author":"Grevelding","year":"2018","journal-title":"Trends Parasitol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.biochem.75.103004.142657","article-title":"Tyrphostins and other tyrosine kinase inhibitors","volume":"75","author":"Levitzki","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-6851(02)00249-9","article-title":"An unusual receptor tyrosine kinase of Schistosoma mansoni contains a Venus Flytrap module","volume":"126","author":"Vicogne","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1051\/parasite\/2008154573","article-title":"Insulin receptors and glucose uptake in the human parasite Schistosoma mansoni","volume":"15","author":"Ahier","year":"2008","journal-title":"Parasite"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Buro, C., Oliveira, K.C., Lu, Z., Leutner, S., Beckmann, S., Dissous, C., Cailliau, K., Verjovski-Almeida, S., and Grevelding, C.G. (2013). Transcriptome Analyses of Inhibitor-treated Schistosome Females Provide Evidence for Cooperating Src-kinase and TGF\u03b2 Receptor Pathways Controlling Mitosis and Eggshell Formation. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003448"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Beckmann, S., Buro, C., Dissous, C., Hirzmann, J., and Grevelding, C.G. (2010). The Syk kinase SmTK4 of Schistosoma mansoni is involved in the regulation of spermatogenesis and oogenesis. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000769"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"You, H., Zhang, W., Jones, M.K., Gobert, G.N., Mulvenna, J., Rees, G., Spanevello, M., Blair, D., Duke, M., and Brehm, K. (2010). Cloning and characterisation of Schistosoma japonicum insulin receptors. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009868"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4155\/fmc.15.31","article-title":"Re-positioning protein-kinase inhibitors against schistosomiasis","volume":"7","author":"Gelmedin","year":"2015","journal-title":"Future Med. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fgene.2014.00238","article-title":"Receptor tyrosine kinases and schistosome reproduction: New targets for chemotherapy","volume":"5","author":"Morel","year":"2014","journal-title":"Front. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.ijpara.2006.06.004","article-title":"Herbimycin A suppresses mitotic activity and egg production of female Schistosoma mansoni","volume":"36","author":"Knobloch","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijpara.2010.01.007","article-title":"Imatinib has a fatal impact on morphology, pairing stability and survival of adult Schistosoma mansoni in vitro","volume":"40","author":"Beckmann","year":"2010","journal-title":"Int. J. Parasitol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00436-019-06224-x","article-title":"The ABL kinase inhibitor imatinib causes phenotypic changes and lethality in adult Schistosoma japonicum","volume":"118","author":"Li","year":"2019","journal-title":"Parasitol. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijantimicag.2012.07.007","article-title":"In vitro efficacy of the anticancer drug imatinib on Echinococcus multilocularis larvae","volume":"40","author":"Hemer","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3389\/fvets.2020.611270","article-title":"Targeting Kinases in Fasciola hepatica: Anthelminthic Effects and Tissue Distribution of Selected Kinase Inhibitors","volume":"7","author":"Morawietz","year":"2020","journal-title":"Front. Vet. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"O\u2019Connell, E.M., Kamenyeva, O., Lustigman, S., Bell, A., and Nutman, T.B. (2017). Defining the target and the effect of imatinib on the filarial c-Abl homologue. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005690"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13071-018-2799-3","article-title":"Heterogeneity in the in vitro susceptibility of Loa loa microfilariae to drugs commonly used in parasitological infections","volume":"11","author":"Njouendou","year":"2018","journal-title":"Parasites Vectors"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/abr.abr_58_19","article-title":"Evaluation of different concentrations of imatinib on the viability of Leishmania major: An In vitro study","volume":"8","author":"Moslehi","year":"2019","journal-title":"Adv. Biomed. Res."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Ju\u00e1rez-Saldivar, A., Barbosa-Cabrera, E., Lara-Ram\u00edrez, E.E., Paz-Gonz\u00e1lez, A.D., Mart\u00ednez-V\u00e1zquez, A.V., Bocanegra-Garc\u00eda, V., Palos, I., Campillo, N.E., and Rivera, G. (2021). Virtual screening of fda-approved drugs against triose phosphate isomerase from entamoeba histolytica and giardia lamblia identifies inhibitors of their trophozoite growth phase. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115943"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Kesely, K.R., Pantaleo, A., Turrini, F.M., Olupot-Olupot, P., and Low, P.S. (2016). Inhibition of an erythrocyte tyrosine kinase with imatinib prevents Plasmodium falciparum egress and terminates parasitemia. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164895"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1056\/NEJMc1712990","article-title":"Reduction of Loa loa Microfilaremia with Imatinib\u2014A Case Report","volume":"377","author":"Nutman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s00216-021-03230-w","article-title":"High-resolution AP-SMALDI MSI as a tool for drug imaging in Schistosoma mansoni","volume":"413","author":"Mokosch","year":"2021","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_96","first-page":"3579","article-title":"Protein Kinases as Potential Targets for Novel Anti-Schistosomal Strategies","volume":"18","author":"Beckmann","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fimmu.2019.00021","article-title":"Smp38 MAP kinase regulation in Schistosoma mansoni: Roles in survival, oviposition, and protection against oxidative stress","volume":"10","author":"Avelar","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"de Andrade, L.F., de Mour\u00e3o, M.M., Geraldo, J.A., Coelho, F.S., Silva, L.L., Neves, R.H., Volpini, A., Machado-Silva, J.R., Araujo, N., and Nacif-Pimenta, R. (2014). Regulation of Schistosoma mansoni Development and Reproduction by the Mitogen-Activated Protein Kinase Signaling Pathway. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002949"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/4\/1414\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:23:04Z","timestamp":1760134984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/4\/1414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,19]]},"references-count":98,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["molecules27041414"],"URL":"https:\/\/doi.org\/10.3390\/molecules27041414","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,19]]}}}